TJ003234

DB16470InvestigationalProtein Based Therapies

TJ003234: Overview.

Mechanism: TJ003234 is an anti-GM-CSF monoclonal antibody, which aims to reduce acute and chronic inflammation in various disease states.
Curator reviewed
Also known as: Plonmarlimab
Code names: TJ003234

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

6Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with TJ003234, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.